Arkolith/Insider Trading/EW/Form 4

Lippis Daniel J.

CVP, TAVREdwards Lifesciences Corp (EW) · full profile →Form 4 · filed May 8, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 8, 2026Tax withholding(F)450$82.76$37K41K
May 7, 2026Grant(A)8K—$042K
May 7, 2026Tax withholding(F)309$83.20$26K41K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 7, 2026Grant(A)40K—$040K
May 7, 2026Grant(A)8K—$08K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001225208-26-005045) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML